<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>风云药谈 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-07T20:25:04+08:00</updated>
  <subtitle>分享、交流、学习</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>第四批集采会有生物制剂（胰岛素）？</title>
    <updated>2020-11-07T18:34:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-07:/s/DkZAB5hVo9G2McL8PWN0ig</id>
    <link href="https://mp.weixin.qq.com/s/DkZAB5hVo9G2McL8PWN0ig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一种新的“招采模式”横空出世，大浙江小单元竞价法，浙江大佬要头疼了！</title>
    <updated>2020-11-06T00:04:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/BCw-NgZqbmbeumtsaZ56Pw</id>
    <link href="https://mp.weixin.qq.com/s/BCw-NgZqbmbeumtsaZ56Pw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一个支架一条华子钱，接下来轮到什么耗材？</title>
    <updated>2020-11-05T21:20:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/HyD71yczwtoeFFCqxmePVA</id>
    <link href="https://mp.weixin.qq.com/s/HyD71yczwtoeFFCqxmePVA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>分层次“带量采”结果落地，外企吃饱内资喝汤！</title>
    <updated>2020-11-04T18:10:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/e33SjrU2dvMWE_PcIhD2HA</id>
    <link href="https://mp.weixin.qq.com/s/e33SjrU2dvMWE_PcIhD2HA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国采中标产品“替代监测大目录”发布，影响几何？</title>
    <updated>2020-11-03T18:21:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/1YugOSjSfEzZ16EF35FIrg</id>
    <link href="https://mp.weixin.qq.com/s/1YugOSjSfEzZ16EF35FIrg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>互联网+医保支付落地，“第四中端”能否上天？</title>
    <updated>2020-11-02T18:38:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/Z2mEG7R6Eq64oAA4bNN9tQ</id>
    <link href="https://mp.weixin.qq.com/s/Z2mEG7R6Eq64oAA4bNN9tQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>50+产品满三家，第四批国采应该快了！</title>
    <updated>2020-10-31T17:58:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-31:/s/a0j-BZe4LkFtTRQBj_U33A</id>
    <link href="https://mp.weixin.qq.com/s/a0j-BZe4LkFtTRQBj_U33A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“五省联盟”17大品种新玩法“凡带量、必轮选”</title>
    <updated>2020-10-29T19:18:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/0YtQKlI1UsK-VyjO7gD-eA</id>
    <link href="https://mp.weixin.qq.com/s/0YtQKlI1UsK-VyjO7gD-eA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>外企将全面落地“药代备案”，内资企业何去何从？</title>
    <updated>2020-10-28T19:25:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/55Pz88zwnJwmwaOsiaTNug</id>
    <link href="https://mp.weixin.qq.com/s/55Pz88zwnJwmwaOsiaTNug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国采第二批半年完成160%，中选使用85%，NB</title>
    <updated>2020-10-27T18:04:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/imV00zz1E6Xi9enlP10RfQ</id>
    <link href="https://mp.weixin.qq.com/s/imV00zz1E6Xi9enlP10RfQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>